These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 29512000)

  • 1. Evaluation of the AJCC 8th Edition Staging System for Pathologically Versus Clinically Staged Intrahepatic Cholangiocarcinoma (iCCA): a Time to Revisit a Dogma? A Surveillance, Epidemiology, and End Results (SEER) Analysis.
    Kamarajah SK
    J Gastrointest Cancer; 2019 Sep; 50(3):392-399. PubMed ID: 29512000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis.
    Kim Y; Moris DP; Zhang XF; Bagante F; Spolverato G; Schmidt C; Dilhoff M; Pawlik TM
    J Surg Oncol; 2017 Nov; 116(6):643-650. PubMed ID: 28608424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis.
    Kamarajah SK; Burns WR; Frankel TL; Cho CS; Nathan H
    Ann Surg Oncol; 2017 Jul; 24(7):2023-2030. PubMed ID: 28213792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis.
    Kamarajah SK; Frankel TL; Sonnenday C; Cho CS; Nathan H
    J Surg Oncol; 2018 Mar; 117(4):644-650. PubMed ID: 29127719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma.
    Spolverato G; Bagante F; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Pawlik TM
    J Surg Oncol; 2017 May; 115(6):696-703. PubMed ID: 28194791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified staging classification for intrahepatic cholangiocarcinoma based on the sixth and seventh editions of the AJCC/UICC TNM staging systems.
    Meng ZW; Pan W; Hong HJ; Chen JZ; Chen YL
    Medicine (Baltimore); 2017 Aug; 96(34):e7891. PubMed ID: 28834905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System.
    Lamarca A; Santos-Laso A; Utpatel K; La Casta A; Stock S; Forner A; Adeva J; Folseraas T; Fabris L; Macias RIR; Krawczyk M; Krawczyk M; Cardinale V; Braconi C; Alvaro D; Evert M; Banales JM; Valle JW;
    Hepatology; 2021 Jun; 73(6):2311-2325. PubMed ID: 33073396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of liver resection on survival for locally advanced intrahepatic cholangiocarcinoma tumors: A propensity score analysis.
    Moustafa M; Fasolo E; Bassi D; D'amico FE; Gringeri E; Pawlik TM; Cillo U
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):632-637. PubMed ID: 31812289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modifications of the AJCC 8th edition staging system for intrahepatic cholangiocarcinoma and proposal for a new staging system by incorporating serum tumor markers.
    Cheng Z; Lei Z; Si A; Yang P; Luo T; Guo G; Zhou J; Wang X; Li Z; Xia Y; Li J; Wang K; Yan Z; Wei W; Hartmann D; Hüser N; Lau WY; Shen F
    HPB (Oxford); 2019 Dec; 21(12):1656-1666. PubMed ID: 31307889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Management of Intrahepatic Cholangiocarcinoma: Defining an Optimal Prognostic Lymph Node Stratification Schema.
    Kim Y; Spolverato G; Amini N; Margonis GA; Gupta R; Ejaz A; Pawlik TM
    Ann Surg Oncol; 2015 Aug; 22(8):2772-8. PubMed ID: 25663595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
    Abdel-Rahman O
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic predictability of the new American Joint Committee on Cancer 8th staging system for distal bile duct cancer: limited usefulness compared with the 7th staging system.
    Kang JS; Lee S; Son D; Han Y; Lee KB; Kim JR; Kwon W; Kim SW; Jang JY
    J Hepatobiliary Pancreat Sci; 2018 Feb; 25(2):124-130. PubMed ID: 29239127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experience.
    Ali SM; Clark CJ; Mounajjed T; Wu TT; Harmsen WS; Reid-Lombardo KM; Truty MJ; Kendrick ML; Farnell MB; Nagorney DM; Que FG
    HPB (Oxford); 2015 Mar; 17(3):244-50. PubMed ID: 25410716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Predictability of American Joint Committee on Cancer 8th Staging System for Perihilar Cholangiocarcinoma: Limited Improvement Compared with the 7th Staging System.
    Lee JW; Lee JH; Park Y; Lee W; Kwon J; Song KB; Hwang DW; Kim SC
    Cancer Res Treat; 2020 Jul; 52(3):886-895. PubMed ID: 32164049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of web-based nomograms for predicting survival status in patients with intrahepatic cholangiocarcinoma depending on the surgical status: a SEER database analysis.
    Liu YG; Jiang ST; Zhang JW; Zhang L; Zhao HT; Sang XT; Lu X; Xu YY
    Sci Rep; 2024 Jan; 14(1):1568. PubMed ID: 38238494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proposed staging system for intrahepatic cholangiocarcinoma.
    Nathan H; Aloia TA; Vauthey JN; Abdalla EK; Zhu AX; Schulick RD; Choti MA; Pawlik TM
    Ann Surg Oncol; 2009 Jan; 16(1):14-22. PubMed ID: 18987916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic comparison of the 7th and 8th editions of the American Joint Committee on Cancer staging system for intrahepatic cholangiocarcinoma.
    Kang SH; Hwang S; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Lee SG
    J Hepatobiliary Pancreat Sci; 2018 Apr; 25(4):240-248. PubMed ID: 29450978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the American Joint Committee on Cancer (AJCC) 8th edition stage system for gastric cancer patients: a population-based analysis.
    He X; Wu W; Lin Z; Ding Y; Si J; Sun LM
    Gastric Cancer; 2018 May; 21(3):391-400. PubMed ID: 29052053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AJCC 7th edition staging classification is more applicable than AJCC 8th edition staging classification for invasive IPMN.
    Fan Z; Cheng H; Jin K; Gong Y; Huang Q; Xu J; Ni Q; Yu X; Liu C; Luo G
    World J Surg Oncol; 2019 Aug; 17(1):137. PubMed ID: 31387646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk prediction in intrahepatic cholangiocarcinoma: Direct comparison of the MEGNA score and the 8th edition of the UICC/AJCC Cancer staging system.
    Hahn F; Müller L; Mähringer-Kunz A; Schotten S; Düber C; Hinrichs JB; Maschke SK; Galle PR; Bartsch F; Lang H; Weinmann A; Kloeckner R
    PLoS One; 2020; 15(2):e0228501. PubMed ID: 32012198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.